KLINSKY STEVEN B
Follow13F filer, CIK 1018327, New York, NY
KLINSKY STEVEN B reported $220,417,000 across 3 holdings for the quarter ended 2015-06-30, in a 13F-HR filed 2015-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-15-001653
Changes against Q1 2015 are not shown: its report omitted holdings under a confidential treatment request (3 positions on file), so every position would read as new.
The filing omits holdings under a confidential treatment request (H8). A later amendment may add them.
- Period
- 2015-06-30
- Reported value
- $220M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q2 2015
Share positions as resolved from 13F-HR 0001172661-15-001653, largest first. % of portfolio is the value over $220,417,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| EVERBANK FINANCIAL CORPORAT…EVERBANK FINANCIAL CORPORATION | 6,732,783 | $132M | 60.02% | The filing omitted confidential holdings, a later amendment may add them. | |||
| NMFCNEW MTN FIN CORP | 3,421,575 | $49.6M | 22.49% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| BELLEROPHON THERAPEUTICS INCBELLEROPHON THERAPEUTICS INC | 4,859,885 | $38.5M | 17.48% | The filing omitted confidential holdings, a later amendment may add them. |
How Q2 2015 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001172661-15-001653 | base | 2015-08-14 | acceptance time not in the bulk data set |